Clinical characteristics and CT features of hepatic epithelioid haemangioendothelioma and comparison with those of liver metastases

Wang, Xiaopeng; Liang, Pan; Lv, Peijie; Li, Rui; Hou, Ping; Gao, Jianbo

doi:10.1186/s13244-021-01143-x

Insights into Imaging

Table 1 Patients basic characteristics and clinical course of HEH

From: Clinical characteristics and CT features of hepatic epithelioid haemangioendothelioma and comparison with those of liver metastases

Case	Classification	Sex	Age(y)	Symptom	Liver function		Tumour mark			Treatment	Follow-up
					ALT	AST	CA199	CA125	HBV		Time (m)	Outcome
1	Solitary	M	48	Abdominal pain	Normal	Normal	Negative	Negative	Negative	TACE	41	no change
2	Solitary	F	35	Asymptomatic	normal	Normal	Negative	Negative	Negative	Hemihepatectomy	4	no change
3	Solitary	F	41	Fever	Normal	Normal	Negative	Negative	Negative	Hemihepatectomy	10	new lesion
4	Multiple	M	42	Asymptomatic	93.58	73.26	negative	negative	Negative	no Treatment	25	alive
5	Multiple	F	47	Asymptomatic	normal	Normal	Negative	Negative	Negative	Hemihepatectomy	13	new lesions
6	Multiple	F	46	Asymptomatic	normal	Normal	Negative	Negative	positive	Hemihepatectomy	62	new lesions
7	Multiple	F	69	Weight loss	normal	Normal	Negative	124.18	negative	TACE	24	reduction
8	Multiple	F	31	Asymptomatic	normal	Normal	Negative	negative	negative	Complex therapy	36	no change
9	multiple	F	55	Weak	normal	Normal	Negative	negative	Negative	No treatment	26	new lesions
10	multiple	F	29	Asymptomatic	normal	Normal	Negative	negative	Negative	complex Therapy	22	new lesions
11	multiple	F	48	Abdominal pain	60.36	normal	negative	negative	negative	unknown	no	unknown
12	multiple	M	38	asymptomatic	88.31	normal	negative	negative	negative	chemotherapy	no	Lost to follow-up
13	diffuse	F	34	poor appetite	106.39	114.68	negative	negative	negative	chemotherapy	19	Enlargement
14	diffuse	M	36	asymptomatic	Normal	Normal	38.95	Negative	Negative	Complex therapy	18	Enlargement
15	diffuse	F	39	asymptomatic	98.17	73.28	negative	negative	Negative	Complex therapy	4	No change
16	diffuse	F	40	abdominal pain	Normal	normal	negative	48.26	Negative	No treatment	18	No change
17	diffuse	F	52	abdominal pain	Normal	normal	negative	62.52	Negative	RFA	10	Reduction
18	diffuse	F	37	abdominal pain	Normal	normal	negative	negative	Negative	Complex therapy	13	Enlargement
19	diffuse	M	71	abdominal pain	102.35	116.87	negative	162.36	Negative	Complex therapy	17	dead
20	diffuse	F	21	asymptomatic	Normal	Normal	Negative	Negative	Negative	Unknown	no	unknown

HEH hepatic epithelioid haemangioendothelioma; M Male; F Female; ALT glutamic-pyruvic transaminase, normal range:0–40. AST glutamic oxalacetic transaminase, normal range 0–40; CA199 carbohydrate antigen 199, normal range 0.01‑37 U/ml; CA125 antigen 125, normal range 0.01‑35U/ml; HBV hepatitis B virus; TACE transcatheter arterial chemoembolisation; RAF radiofrequency; y year; m month

Back to article page